Gaurav Shah
CEO @ Rocket Pharmaceuticals
New York, United States
Gaurav Shah is a CEO at Rocket Pharmaceuticals.
Last updated:
For AI agents: llms.txt
About Rocket Pharmaceuticals
Rocket Pharmaceuticals is an emerging biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. The Company’s lead program is a lentiviral-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure andpotentially cancer. Preclinical studies of additional bone marrow-derived disorders are ongoing and target Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-1 (LAD-1) and Infantile Malignant Osteopetrosis. The Company is also developing an AAV-based gene therapy program for an undisclosed rare pediatric disease.
Rocket Pharmaceuticals Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Gaurav Shah
CEO
|
|||
Carlos Garcia Parada
Chief Financial Officer
|
|||
Gayatri Rao
Chief Development Officer of LVV, SVP
|
|||
Isabel Carmona
SVP & Chief Human Resources Officer
|
|||
Jonathan Schwartz
Chief Medical Officer & Clinical Development, SVP
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
